Atlas Trials

Study of Ruxolitinib in Pancreatic Cancer Patients

Clinical trial NCT01423604 · COMPLETED

Trial details

NCT number
NCT01423604
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2011-07-01
Primary completion
2013-06-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.